forecast
Pharma pullback from rare diseases threatens progress
Because pharma has pulled back from rare diseases, Zaks's colleagues in rare disease face challenges, and the economic incentives for innovation cannot be assumed to persist without careful policy and reimbursement design.
forecastpending
Speaker
Tal ZaksEvidence Quote
“we need to be super careful and super mindful of the policy implications”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...